Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{$index + 1}}. {{ watchedTerm.term }} ({{watchedTerm.accId}})
{{gene.symbol}}: {{ gene.description }}
You must be logged in to use this feature
{{ loginError }}
Select categories you would like to watch. Updates to this gene will be sent to {{ username }}
x
Send Message
Gene: Nipal3 (NIPA-like domain containing 3) Rattus norvegicus
Analyze
Symbol:
Nipal3
Name:
NIPA-like domain containing 3
RGD ID:
1563439
Description:
Predicted to enable magnesium ion transmembrane transporter activity. Predicted to be involved in magnesium ion transport. Predicted to be active in membrane. Orthologous to human NIPAL3 (NIPA like domain containing 3); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; bisphenol A; DDT.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
LOC502990; NIPA-like protein 3; Npal3; RGD1563439; similar to hypothetical protein dJ462O23.2
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 152,970,934 - 153,010,006 (-) NCBI GRCr8 GRCr8 GRCr8 GRCr8 Ensembl 5 152,968,910 - 153,008,845 (-) Ensembl GRCr8 mRatBN7.2 5 147,687,310 - 147,725,838 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 147,685,288 - 147,726,351 (-) Ensembl mRatBN7.2 Rnor_6.0 5 153,808,169 - 153,843,961 (-) NCBI Rnor_6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 153,807,955 - 153,840,178 (-) Ensembl rn6 Rnor6.0 Rnor_5.0 5 157,576,870 - 157,610,330 (-) NCBI Rnor_5.0 Rnor_5.0 rn5 RGSC_v3.4 5 154,227,507 - 154,259,618 (-) NCBI RGSC_v3.4 RGSC_v3.4 rn4 Celera 5 146,107,573 - 146,136,068 (-) NCBI Celera Cytogenetic Map 5 q36 NCBI
JBrowse:
Imported Disease Annotations - ClinVar
Imported Disease Annotations - CTD
Only show annotations with direct experimental evidence (0 objects hidden)
Nipal3 Rat 1,2-dichloroethane decreases expression ISO Nipal3 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of NIPAL3 mRNA CTD PMID:28960355 Nipal3 Rat 1,2-dimethylhydrazine multiple interactions ISO Nipal3 (Mus musculus) 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NIPAL3 mRNA CTD PMID:22206623 Nipal3 Rat 1,2-dimethylhydrazine decreases expression ISO Nipal3 (Mus musculus) 6480464 1,2-Dimethylhydrazine results in decreased expression of NIPAL3 mRNA CTD PMID:22206623 Nipal3 Rat 17beta-estradiol increases expression ISO Nipal3 (Mus musculus) 6480464 Estradiol results in increased expression of NIPAL3 mRNA CTD PMID:39298647 Nipal3 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Nipal3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of NIPAL3 mRNA CTD PMID:26377647 Nipal3 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NIPAL3 mRNA CTD PMID:32109520 Nipal3 Rat 2-palmitoylglycerol increases expression ISO NIPAL3 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of NIPAL3 mRNA CTD PMID:37199045 Nipal3 Rat 4,4'-sulfonyldiphenol decreases expression ISO Nipal3 (Mus musculus) 6480464 bisphenol S results in decreased expression of NIPAL3 mRNA CTD PMID:39298647 Nipal3 Rat 4,4'-sulfonyldiphenol increases methylation ISO NIPAL3 (Homo sapiens) 6480464 bisphenol S results in increased methylation of NIPAL3 gene CTD PMID:31601247 Nipal3 Rat 4,4'-sulfonyldiphenol affects methylation ISO Nipal3 (Mus musculus) 6480464 bisphenol S affects the methylation of NIPAL3 exon; bisphenol S affects the methylation of NIPAL3 more ... CTD PMID:31683443|PMID:33297965 Nipal3 Rat 4-hydroxyphenyl retinamide increases expression ISO Nipal3 (Mus musculus) 6480464 Fenretinide results in increased expression of NIPAL3 mRNA CTD PMID:28973697 Nipal3 Rat aflatoxin B1 decreases methylation ISO NIPAL3 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of NIPAL3 gene CTD PMID:27153756 Nipal3 Rat antirheumatic drug decreases expression ISO NIPAL3 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of NIPAL3 mRNA CTD PMID:24449571 Nipal3 Rat aristolochic acid A increases expression ISO NIPAL3 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of NIPAL3 mRNA CTD PMID:33212167 Nipal3 Rat arsenite(3-) multiple interactions ISO NIPAL3 (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to NIPAL3 mRNA] CTD PMID:32406909 Nipal3 Rat arsenous acid increases expression ISO NIPAL3 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of NIPAL3 mRNA CTD PMID:26705709 Nipal3 Rat avobenzone increases expression ISO NIPAL3 (Homo sapiens) 6480464 avobenzone results in increased expression of NIPAL3 mRNA CTD PMID:31016361 Nipal3 Rat benzo[a]pyrene decreases expression ISO NIPAL3 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of NIPAL3 mRNA CTD PMID:26238291 Nipal3 Rat benzo[a]pyrene decreases methylation ISO NIPAL3 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of NIPAL3 5' UTR; Benzo(a)pyrene results in decreased methylation of more ... CTD PMID:27901495 Nipal3 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NIPAL3 mRNA CTD PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998 Nipal3 Rat bisphenol A decreases methylation ISO NIPAL3 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of NIPAL3 gene CTD PMID:31601247 Nipal3 Rat butanal decreases expression ISO NIPAL3 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of NIPAL3 mRNA CTD PMID:26079696 Nipal3 Rat carbon nanotube decreases expression ISO Nipal3 (Mus musculus) 6480464 Nanotubes, Carbon analog results in decreased expression of NIPAL3 mRNA; Nanotubes, Carbon results in decreased more ... CTD PMID:25554681|PMID:25620056 Nipal3 Rat cisplatin multiple interactions ISO NIPAL3 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of NIPAL3 mRNA CTD PMID:27392435 Nipal3 Rat cisplatin increases expression ISO NIPAL3 (Homo sapiens) 6480464 Cisplatin results in increased expression of NIPAL3 mRNA CTD PMID:27392435 Nipal3 Rat cyclosporin A decreases expression ISO NIPAL3 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of NIPAL3 mRNA CTD PMID:20106945 Nipal3 Rat DDT increases methylation EXP 6480464 DDT results in increased methylation of NIPAL3 gene CTD PMID:30207508 Nipal3 Rat decabromodiphenyl ether multiple interactions EXP 6480464 [Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in more ... CTD PMID:32207525 Nipal3 Rat diarsenic trioxide increases expression ISO NIPAL3 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of NIPAL3 mRNA CTD PMID:26705709 Nipal3 Rat dioxygen multiple interactions ISO Nipal3 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NIPAL3 mRNA CTD PMID:30529165 Nipal3 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of NIPAL3 mRNA CTD PMID:29391264 Nipal3 Rat entinostat increases expression ISO NIPAL3 (Homo sapiens) 6480464 entinostat results in increased expression of NIPAL3 mRNA CTD PMID:27188386 Nipal3 Rat ethanol affects expression ISO Nipal3 (Mus musculus) 6480464 Ethanol affects the expression of NIPAL3 mRNA CTD PMID:30319688 Nipal3 Rat ethyl methanesulfonate increases expression ISO NIPAL3 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of NIPAL3 mRNA CTD PMID:23649840 Nipal3 Rat fenthion decreases expression ISO Nipal3 (Mus musculus) 6480464 Fenthion results in decreased expression of NIPAL3 mRNA CTD PMID:34813904 Nipal3 Rat folic acid multiple interactions ISO Nipal3 (Mus musculus) 6480464 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NIPAL3 mRNA CTD PMID:22206623 Nipal3 Rat fulvestrant increases methylation ISO NIPAL3 (Homo sapiens) 6480464 Fulvestrant results in increased methylation of NIPAL3 gene CTD PMID:31601247 Nipal3 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of NIPAL3 mRNA CTD PMID:33387578 Nipal3 Rat hydroquinone decreases expression ISO NIPAL3 (Homo sapiens) 6480464 hydroquinone results in decreased expression of NIPAL3 mRNA CTD PMID:31256213 Nipal3 Rat lead(0) affects expression ISO NIPAL3 (Homo sapiens) 6480464 Lead affects the expression of NIPAL3 mRNA CTD PMID:28903495 Nipal3 Rat maneb multiple interactions ISO Nipal3 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of NIPAL3 mRNA CTD PMID:36117858 Nipal3 Rat manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of NIPAL3 mRNA CTD PMID:28801915 Nipal3 Rat methidathion decreases expression ISO Nipal3 (Mus musculus) 6480464 methidathion results in decreased expression of NIPAL3 mRNA CTD PMID:34813904 Nipal3 Rat methyl methanesulfonate increases expression ISO NIPAL3 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of NIPAL3 mRNA CTD PMID:23649840 Nipal3 Rat N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of NIPAL3 mRNA CTD PMID:28801915 Nipal3 Rat nitrates multiple interactions ISO Nipal3 (Mus musculus) 6480464 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NIPAL3 more ... CTD PMID:35964746 Nipal3 Rat ozone multiple interactions ISO Nipal3 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... CTD PMID:34911549 Nipal3 Rat ozone multiple interactions ISO NIPAL3 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of NIPAL3 mRNA CTD PMID:35430440 Nipal3 Rat paraquat multiple interactions ISO Nipal3 (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of NIPAL3 mRNA CTD PMID:36117858 Nipal3 Rat pirinixic acid increases expression ISO Nipal3 (Mus musculus) 6480464 pirinixic acid results in increased expression of NIPAL3 mRNA CTD PMID:23811191 Nipal3 Rat resveratrol multiple interactions ISO NIPAL3 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of NIPAL3 mRNA CTD PMID:23557933 Nipal3 Rat silicon dioxide decreases expression ISO NIPAL3 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of NIPAL3 mRNA CTD PMID:25895662 Nipal3 Rat sodium arsenate increases expression ISO Nipal3 (Mus musculus) 6480464 sodium arsenate results in increased expression of NIPAL3 mRNA CTD PMID:39847705 Nipal3 Rat sodium arsenite affects methylation ISO NIPAL3 (Homo sapiens) 6480464 sodium arsenite affects the methylation of NIPAL3 gene CTD PMID:28589171 Nipal3 Rat sodium arsenite decreases expression ISO NIPAL3 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of NIPAL3 mRNA CTD PMID:38568856 Nipal3 Rat sunitinib decreases expression ISO NIPAL3 (Homo sapiens) 6480464 Sunitinib results in decreased expression of NIPAL3 mRNA CTD PMID:31533062 Nipal3 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of NIPAL3 mRNA CTD PMID:33387578 Nipal3 Rat thimerosal decreases expression ISO NIPAL3 (Homo sapiens) 6480464 Thimerosal results in decreased expression of NIPAL3 mRNA CTD PMID:27188386 Nipal3 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of NIPAL3 mRNA CTD PMID:34492290 Nipal3 Rat titanium dioxide decreases expression ISO Nipal3 (Mus musculus) 6480464 titanium dioxide results in decreased expression of NIPAL3 mRNA CTD PMID:29264374 Nipal3 Rat titanium dioxide increases methylation ISO Nipal3 (Mus musculus) 6480464 titanium dioxide results in increased methylation of NIPAL3 promoter alternative form CTD PMID:35295148 Nipal3 Rat titanium dioxide decreases methylation ISO Nipal3 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of NIPAL3 promoter alternative form CTD PMID:35295148 Nipal3 Rat triphenyl phosphate affects expression ISO NIPAL3 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of NIPAL3 mRNA CTD PMID:37042841 Nipal3 Rat troglitazone increases expression ISO Nipal3 (Mus musculus) 6480464 troglitazone results in increased expression of NIPAL3 mRNA CTD PMID:28973697 Nipal3 Rat tungsten decreases expression ISO Nipal3 (Mus musculus) 6480464 Tungsten results in decreased expression of NIPAL3 mRNA CTD PMID:30912803 Nipal3 Rat urethane increases expression ISO NIPAL3 (Homo sapiens) 6480464 Urethane results in increased expression of NIPAL3 mRNA CTD PMID:28818685 Nipal3 Rat valproic acid affects expression ISO NIPAL3 (Homo sapiens) 6480464 Valproic Acid affects the expression of NIPAL3 mRNA CTD PMID:25979313 Nipal3 Rat valproic acid increases expression ISO NIPAL3 (Homo sapiens) 6480464 Valproic Acid results in increased expression of NIPAL3 mRNA CTD PMID:23179753|PMID:27188386
QTLs in Region (GRCr8)
10053720 Scort26 Serum corticosterone level QTL 26 2.06 0.0147 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 5 130249266 172190305 Rat 1549845 Scl44 Serum cholesterol level QTL 44 6 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 5 44924861 153890773 Rat 8552960 Pigfal15 Plasma insulin-like growth factor 1 level QTL 15 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 116702075 161702075 Rat 1354583 Despr3 Despair related QTL3 4.98 0.0002 locomotor behavior trait (VT:0001392) amount of time spent in voluntary immobility (CMO:0001043) 5 132930505 172190305 Rat 61444 Strs2 Sensitivity to stroke QTL 2 4.7 cerebrum integrity trait (VT:0010549) post-insult time to onset of cerebrovascular lesion (CMO:0002343) 5 141212838 172190305 Rat 1300119 Bp180 Blood pressure QTL 180 3.82 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 5 149642129 171146538 Rat 61452 Ciaa5 CIA Autoantibody QTL 5 3.5 blood autoantibody amount (VT:0003725) calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281) 5 99905133 172190305 Rat 70156 Niddm30 Non-insulin dependent diabetes mellitus QTL 30 3.98 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 5 134369218 156289444 Rat 8552908 Pigfal4 Plasma insulin-like growth factor 1 level QTL 4 6.6 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 133789363 172190305 Rat 1331803 Rf32 Renal function QTL 32 2.798 kidney blood vessel physiology trait (VT:0100012) absolute change in renal vascular resistance (CMO:0001900) 5 134369199 172190305 Rat 61393 Bp7 Blood pressure QTL 7 4.5 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 65089051 166764498 Rat 7794791 Mcs33 Mammary carcinoma susceptibility QTL 33 1.93 mammary gland integrity trait (VT:0010552) mammary tumor incidence/prevalence measurement (CMO:0000946) 5 136631198 172190305 Rat 7207486 Bss109 Bone structure and strength QTL 109 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 5 112142946 157142946 Rat 7207481 Bss106 Bone structure and strength QTL 106 7.9 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 5 112142946 157142946 Rat 1302790 Scl20 Serum cholesterol level QTL 20 6.4 0.0001 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 110770739 155770739 Rat 1598861 Cm64 Cardiac mass QTL 64 2.9 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 133081618 172190305 Rat 631263 Cm24 Cardiac mass QTL 24 3.5 heart mass (VT:0007028) heart left ventricle weight to body weight ratio (CMO:0000530) 5 149805999 162987697 Rat 1578766 Tcas11 Tongue tumor susceptibility QTL 11 4.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 5 51657967 166600247 Rat 631505 Bp103 Blood pressure QTL 103 3.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 138002522 170842766 Rat 1581505 Rf54 Renal function QTL 54 kidney physiology trait (VT:0002136) kidney 20-HETE level (CMO:0001854) 5 133270647 172190305 Rat 1549838 Bss4 Bone structure and strength QTL 4 9.2 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 5 112142946 157142946 Rat 2317753 Glom24 Glomerulus QTL 24 3.1 kidney glomerulus integrity trait (VT:0010546) kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269) 5 141764300 172190305 Rat 1331721 Bp210 Blood pressure QTL 210 3.413 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 5 148093485 172129029 Rat 8694169 Bw148 Body weight QTL 148 5 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 133789363 172190305 Rat 1581510 Cm54 Cardiac mass QTL 54 3.4 0.05 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 5 125969677 172190305 Rat 1576312 Emca8 Estrogen-induced mammary cancer QTL 8 4.1 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 55124766 172190305 Rat 2317056 Wbc3 White blood cell count QTL 3 2.51 0.01 leukocyte quantity (VT:0000217) white blood cell count (CMO:0000027) 5 111236572 156236572 Rat 724525 Bp147 Blood pressure QTL 147 4.3 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 131708216 172190305 Rat 1598847 Cm62 Cardiac mass QTL 62 3.4 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 114131300 159131300 Rat 2293642 Bss37 Bone structure and strength QTL 37 4.64 0.0001 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 5 125969677 156302135 Rat 2313096 Bmd78 Bone mineral density QTL 78 3.1 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 5 149661912 166600247 Rat 8694441 Bw169 Body weight QTL 169 17.61 0.001 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 5 116702075 161702075 Rat 7207488 Bss110 Bone structure and strength QTL 1 8.4 femur strength trait (VT:0010010) femur stiffness (CMO:0001674) 5 112142946 157142946 Rat 7207491 Bss112 Bone structure and strength QTL 112 7 femur morphology trait (VT:0000559) femur midshaft cortical cross-sectional area (CMO:0001663) 5 112142946 157142946 Rat 8694389 Bw160 Body weight QTL 160 6.17 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 5 116702075 161702075 Rat 1354598 Srn6 Serum renin concentration QTL 6 3.8 blood renin amount (VT:0003349) plasma renin activity level (CMO:0000116) 5 74335621 156302135 Rat 8694198 Abfw3 Abdominal fat weight QTL 3 16.13 0.001 visceral adipose mass (VT:0010063) abdominal fat pad weight to body weight ratio (CMO:0000095) 5 116702075 161702075 Rat 1298089 Scl14 Serum cholesterol level QTL 14 5.8 0.0004 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 114131300 159131300 Rat 1598819 Bp292 Blood pressure QTL 292 4.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 133081618 172190305 Rat 1358187 Emca1 Estrogen-induced mammary cancer QTL 1 4.4 mammary gland integrity trait (VT:0010552) post-insult time to mammary tumor formation (CMO:0000345) 5 104262817 153890625 Rat